Economic impact of new interventional therapies: are we asking the right questions?
Publication
, Journal Article
Kong, DF; Mark, DB
Published in: J Am Coll Cardiol
November 2, 2004
Duke Scholars
Published In
J Am Coll Cardiol
DOI
ISSN
0735-1097
Publication Date
November 2, 2004
Volume
44
Issue
9
Start / End Page
1809 / 1811
Location
United States
Related Subject Headings
- Saphenous Vein
- Recombinant Proteins
- Postoperative Complications
- Platelet Glycoprotein GPIIb-IIIa Complex
- Peptide Fragments
- Humans
- Hospitalization
- Hirudins
- Heparin
- Embolism
Citation
APA
Chicago
ICMJE
MLA
NLM
Kong, D. F., & Mark, D. B. (2004). Economic impact of new interventional therapies: are we asking the right questions? J Am Coll Cardiol, 44(9), 1809–1811. https://doi.org/10.1016/j.jacc.2004.08.010
Kong, David F., and Daniel B. Mark. “Economic impact of new interventional therapies: are we asking the right questions?” J Am Coll Cardiol 44, no. 9 (November 2, 2004): 1809–11. https://doi.org/10.1016/j.jacc.2004.08.010.
Kong DF, Mark DB. Economic impact of new interventional therapies: are we asking the right questions? J Am Coll Cardiol. 2004 Nov 2;44(9):1809–11.
Kong, David F., and Daniel B. Mark. “Economic impact of new interventional therapies: are we asking the right questions?” J Am Coll Cardiol, vol. 44, no. 9, Nov. 2004, pp. 1809–11. Pubmed, doi:10.1016/j.jacc.2004.08.010.
Kong DF, Mark DB. Economic impact of new interventional therapies: are we asking the right questions? J Am Coll Cardiol. 2004 Nov 2;44(9):1809–1811.
Published In
J Am Coll Cardiol
DOI
ISSN
0735-1097
Publication Date
November 2, 2004
Volume
44
Issue
9
Start / End Page
1809 / 1811
Location
United States
Related Subject Headings
- Saphenous Vein
- Recombinant Proteins
- Postoperative Complications
- Platelet Glycoprotein GPIIb-IIIa Complex
- Peptide Fragments
- Humans
- Hospitalization
- Hirudins
- Heparin
- Embolism